TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

VolverVolver

Resultados 125 resultados LastUpdate Última actualización 20/01/2020 [17:32:00] pdf PDF

Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days

Página1 de 5 nextPage   por página


ANALYSIS OF GLUCOSE MEDIAN, VARIABILITY, AND HYPOGLYCEMIA RISK FOR THERAPY GUIDANCE

NºPublicación: US2020015756A1 16/01/2020

Solicitante:

ABBOTT DIABETES CARE INC [US]

US_2014188400_PA

Resumen de: US2020015756A1

A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.

traducir

Continuous glucose monitoring system and method

NºPublicación: US2020015720A1 16/01/2020

Solicitante:

SANVITA MEDICAL LLC [US]

BR_112019012600_A2

Resumen de: US2020015720A1

A continuous glucose monitoring system and method has an inserter assembly for inserting a sensor through the skin and into subcutaneous tissue where an inserter housing with the sensor remains on the skin after insertion, a sensor housing cover attachable to the sensor housing after insertion where the sensor housing cover has an electronic module and a battery, and an electronic device equipped with wireless communication for communicating with the electronic module of the sensor housing cover assembly, the electronic device configured for receiving input signals from the sensor, converting the input signals to analyte date, displaying the analyte data on a user interface of the electronic device, storing the data for recall, and creating and/or sending reports of the data.

traducir

MULTI-STREAM DATA COLLECTION SYSTEM FOR NONINVASIVE MEASUREMENT OF BLOOD CONSTITUENTS

NºPublicación: US2020015716A1 16/01/2020

Solicitante:

MASIMO CORP [US]

US_2019374135_A1

Resumen de: US2020015716A1

The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.

traducir

INFUSION PUMP SYSTEMS AND METHODS

NºPublicación: US2020016335A1 16/01/2020

Solicitante:

TANDEM DIABETES CARE INC [US]

Resumen de: US2020016335A1

Embodiments are directed to portable infusion devices, systems, and methods of using the same for dispensing materials. In some cases, the devices, systems and methods may be used for infusing a material such as medicament, e.g., insulin, into a body in need thereof.

traducir

Method, System, and Computer Readable Medium for Controlling Insulin Delivery Using Retrospective Virtual Basal Rates

NºPublicación: US2020016336A1 16/01/2020

Solicitante:

UNIV VIRGINIA PATENT FOUNDATION [US]

Resumen de: US2020016336A1

Equivalent insulin pump retrospective virtual basal rates for daily injections are constructed from planned insulin injections according to a virtual basal rate profile developed for a patient, and a database of historical insulin injections, i.e. basal injections actually administered by the patient, providing a unified framework for analysis, design, optimization, and adaptation of MDI (multiple daily injections) and CSII (continuous subcutaneous insulin infusion (i.e. insulin pump)) treatment parameters for patients with diabetes.

traducir

AUTOMATED SYSTEM FOR CONTROLLING THE BLOOD GLUCOSE LEVEL OF A PATIENT

NºPublicación: US2020015738A1 16/01/2020

Solicitante:

COMMISSARIAT A IENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES [FR]

JP_2019528913_A

Resumen de: US2020015738A1

A blood sugar regulation system including: a blood sugar sensor; an insulin injection device; and a processing and control unit predicting the future evolution of the blood sugar based on a physiological model and accordingly controlling the insulin injection device, wherein the processing and control unit is capable of: a) implementing a calibration of the model by taking into account a history of the measured blood sugar; b) at the end of the calibration step, determining whether the model is satisfactory or not based on at least one numerical indicator representative of the error between the blood sugar estimated based on the model and the real blood sugar measured by the sensor; and c) if the quality of the model is not satisfactory, controlling the insulin injection device without taking into account the predictions made from the model.

traducir

Method and system for monitoring a diabetes treatment plan

NºPublicación: AU2017420200A1 16/01/2020

Solicitante:

CHAN SIDNEY SOONG LING

CA_3064598_A1

Resumen de: AU2017420200A1

A method and system for monitoring the effectiveness of a patient's diabetes treatment plan by predicting, on a frequent basis, the patient's glycated hemoglobin (A1c) based on the patient's blood glucose (BG) may include applying a plurality of A1c models to a BG data set of the patient so as to obtain a plurality of calculated A1c values and identifying a best fit model amongst the plurality of A1c models by evaluating the plurality of calculated A1c values against at least one measured A1c value; calculating a predicted A1c value by applying the identified best fit model to the BG data set. Some embodiments may further include evaluating the predicted A1c value against a set of escalation rules to determine whether an escalation alert is required; alerting the patient's healthcare provider when it is determined the escalation alert is required; and outputting the predicted A1c value to the patient.

traducir

METHOD, SYSTEM AND COMPUTER READABLE MEDIUM FOR PREDICTIVE HYPOGLYCEMIA DETECTION FOR MILD TO MODERATE EXERCISE

NºPublicación: US2020015757A1 16/01/2020

Solicitante:

UNIV VIRGINIA PATENT FOUNDATION [US]

US_2018055452_PA

Resumen de: US2020015757A1

A system for generating a hypoglycemia risk signal associated with exercise-induced Hypoglycemia. The system can include a processor configured to obtain a blood glucose signal (BGstart), a ratio of absolute insulin on board over total daily insulin signal (IOBabs/TDI), and an initial glycemic slope signal (S0); generate a hypoglycemia risk signal based on a hypoglycemia prediction algorithm that determines the probability of a user being hypoglycemic during or after exercise based on the obtained BGstarts, IOBabs/TDI and S0.

traducir

METHOD TO DETERMINE INDIVIDUALIZED INSULIN SENSITIVITY AND OPTIMAL INSULIN DOSE BY LINEAR REGRESSION, AND RELATED SYSTEMS

NºPublicación: US2020015760A1 16/01/2020

Solicitante:

BIGFOOT BIOMEDICAL INC [US]

US_2016162797_PA

Resumen de: US2020015760A1

This invention relates to a method and a device for predicting the glucose concentration of a subject and recommending therapeutic action. The responses of the user's glucose to administered doses of insulin, dietary carbohydrates, and other factors influencing glucose concentration are measured individually for a given user. Once these responses are learned as a function of time, the method and device can receive information about the factors that have been recently or will soon be administered and can recommend which other factors should also be administered.

traducir

SYSTEM AND METHOD FOR EDUCATING USERS, INCLUDING RESPONDING TO PATTERNS

NºPublicación: US2020020247A1 16/01/2020

Solicitante:

DEXCOM INC [US]

AU_2019202044_A1

Resumen de: US2020020247A1

Provided are systems and methods using which users may learn and become familiar with the effects of various aspects of their lifestyle on their health, e.g., users may learn about how food and/or exercise affects their glucose level and other physiological parameters, as well as overall health. In some cases the user selects a program to try; in other cases, a computing environment embodying the system suggests programs to try, including on the basis of pattern recognition, i.e., by the computing environment determining how a user could improve a detected pattern in some way. In this way, users such as type II diabetics or even users who are only prediabetic or non-diabetic may learn healthy habits to benefit their health.

traducir

CHEMICAL ABLATION AND METHOD OF TREATMENT FOR VARIOUS DISEASES

NºPublicación: US2020016379A1 16/01/2020

Solicitante:

NEUROTRONIC INC [US]

US_2020009355_A1

Resumen de: US2020016379A1

Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.

traducir

FEEDBACK PREDICTIVE CONTROL APPROACH FOR PROCESSES WITH TIME DELAY IN THE MANIPULATED VARIABLE

NºPublicación: US2020016337A1 16/01/2020

Solicitante:

UNIV IOWA STATE RES FOUND INC [US]

Resumen de: US2020016337A1

This invention relates to a feedback predictive controller, systems comprising and methods employing the same. Preferably the feedback predictive controller and/or systems comprising the feedback predictive controller are part of an automatic insulin delivery system. The methods described herein can be used to control blood glucose concentration in a patient with diabetes. Preferably, the insulin delivery system is an artificial pancreas.

traducir

BLOOD GLUCOSE CONTROL SYSTEM

NºPublicación: EP3594961A1 15/01/2020

Solicitante:

UNIV BOSTON [US]
MASSACHUSETTS GEN HOSPITAL [US]

US_2017095612_A1

Resumen de: EP3594961A1

Techniques are used for adaptation of drug-administration parameters that control insulin delivery in a blood glucose control system. One technique provides relatively long-term adaptation of a nominal basal infusion rate around which the infusion of basal insulin is automatically modulated. This technique enables the system to adapt to longer-term changes in a patient's needs such as may arise from growth, illness, hormonal fluctuations, physical activity, aging, etc. Another technique provides similar adaptation of the size of priming doses of insulin provided at mealtimes, offering the potential of overall better glycemic control in individuals and also providing the adaptation to longer-term changes in a patient's needs. Both techniques may employ adaptation calculations using a receding-horizon window of recent values of the adapted parameter. The system may also deliver doses of a counter-regulatory agent (e.g., glucagon) to the subject in response to information about estimated accumulation of exogenously infused insulin (either subcutaneously, intramuscularly, intraperitoneally, or intravenously) and/or the effect that insulin might have on glucose levels (either blood glucose concentration or interstitial fluid glucose concentration).

traducir

BLOOD GLUCOSE MEASUREMENT DEVICE AND METHOD TO AUTOMATICALLY DETERMINE BLOOD GLUCOSE UNIT

NºPublicación: EP3593717A1 15/01/2020

Solicitante:

PHILOSYS CO LTD [KR]

US_2020008720_A1

Resumen de: EP3593717A1

Provided is a blood glucose measurement device and method. The blood glucose measurement device may determine a blood glucose unit to be provided to a user based on a user input and a region in which the device is positioned, and provide blood glucose data to the user using the determined blood glucose unit through a display.

traducir

MEDICAL MODULE FOR DRUG DELIVERY PEN

NºPublicación: EP3593844A1 15/01/2020

Solicitante:

LIFESCAN INC [US]

EP_3593845_A1

Resumen de: EP3593844A1

Various embodiments of a medical module are provided which includes a primary module housing, a secondary module housing, a dosage sensor, a power source, and a microcontroller. The module is configured to be attached to a disposable drug delivery pen or a reusable drug delivery pen so that the module may: determine dosage selected, injection of selected dosage, duration of injection, time of injection, whether the pen has been primed or shaken to thoroughly mix up insulin mixtures, trans-mit information relating to insulin dosage and injection to a data management unit, provide reminders, error warning or messages on improper usage or reusage of needles, track amount of drug remaining on board the pen or duration of usage of pen with re-spect to expiry of the drug on board, or provide an audible alarm for locating misplaced pen and module.

traducir

MEDICAL MODULE FOR DRUG DELIVERY PEN

NºPublicación: EP3593845A1 15/01/2020

Solicitante:

LIFESCAN INC [US]

EP_3593844_A1

Resumen de: EP3593845A1

Various embodiments of a medical module are provided which includes a primary module housing, a secondary module housing, a dosage sensor, a power source, and a microcontroller. The module is configured to be attached to a disposable drug delivery pen or a reusable drug delivery pen so that the module may: determine dosage selected, injection of selected dosage, duration of injection, time of injection, whether the pen has been primed or shaken to thoroughly mix up insulin mixtures, trans-mit information relating to insulin dosage and injection to a data management unit, provide reminders, error warning or messages on improper usage or reusage of needles, track amount of drug remaining on board the pen or duration of usage of pen with re-spect to expiry of the drug on board, or provide an audible alarm for locating misplaced pen and module.

traducir

METHOD, SYSTEM, AND COMPUTER PROGRAM PRODUCT FOR IMPROVING THE ACCURACY OF GLUCOSE SENSORS USING INSULIN DELIVERY OBSERVATION IN DIABETES

NºPublicación: EP3593711A1 15/01/2020

Solicitante:

THE UNIV OF VIRGINIA PATENT FOUNDATION [US]

US_2013079613_A1

Resumen de: EP3593711A1

Method and System for providing a signal from an insulin pump, artificial pancreas, or another insulin delivery device as a source of information for improving the accuracy of a continuous glucose sensor (CGS). The effect of using insulin information to enhance sensor accuracy is most prominent at low blood glucose levels, i.e. in the hypoglycemic range, which is critical for any treatment. A system for providing a filtering/state estimation methodology that may be used to determine a glucose state estimate at timet-τ. The estimation may be extrapolated to some future time t and then the extrapolated value is used to extract the blood glucose component. The blood glucose component of the extrapolation and the output of the CGS are weighted and used to estimate the blood glucose level of a subject.

traducir

SURFACE-COATED CONTINUOUS GLUCOSE MONITORS

NºPublicación: US2020008718A1 09/01/2020

Solicitante:

MASSACHUSETTS INST TECHNOLOGY [US]
CHILDRENS MEDICAL CT CORP [US]

CN_109563199_A

Resumen de: US2020008718A1

CGMs containing a sensor electrode that is partially or completely coated with one or more layers of a material containing zwitterionic polymers are disclosed. With just a single calibration after implantation, CGMs containing the zwitterionic polymer coatings show reduced discordance between detected and actual blood glucose levels, during the crucial first one to three days, where current commercially available CGMs tend to show discordance with actual blood glucose levels.

traducir

Multiplexed Transdermal Extraction and Detection Devices for Non-Invasive Monitoring of Substances and Methods of Use

NºPublicación: US2020008717A1 09/01/2020

Solicitante:

THE UNIV OF BATH [GB]

JP_2019516452_A

Resumen de: US2020008717A1

Multiplexed transdermal extraction and detection devices and systems for non-invasive monitoring of substances, such as glucose, are disclosed, as are methods of using these devices for substance monitoring in subjects.

traducir

SYSTEM AND METHOD FOR ASSESSING RISK ASSOCIATED WITH A GLUCOSE STATE

NºPublicación: US2020008723A1 09/01/2020

Solicitante:

ROCHE DIABETES CARE INC [US]

JP_2015532138_A

Resumen de: US2020008723A1

A system and method is provided for analyzing a glucose state. A method may include identifying a target glucose state and an initial glucose state. The method may include calculating a target return path for a transition from the initial glucose state to the target glucose state. The target return path may comprise at least one intermediate glucose state associated with the transition from the initial glucose state to the target glucose state. The target return path may be calculated based on a hazard associated with the at least one intermediate glucose state of the target return path.

traducir

CHEMICAL ABLATION AND METHOD OF TREATMENT FOR VARIOUS DISEASES

NºPublicación: US2020009355A1 09/01/2020

Solicitante:

NEUROTRONIC INC [US]

US_2020016379_A1

Resumen de: US2020009355A1

Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspensions of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.

traducir

TRAIN-LIKE PHARMACEUTICAL CONFIGURATION, APPARATUS FOR PREPARATION AND STORAGE DEVICE THEREOF

NºPublicación: US2020008764A1 09/01/2020

Solicitante:

DONG YONGHUA [US]
DONG RUI [US]

KR_20190135021_A

Resumen de: US2020008764A1

The present invention provides a train-like pharmaceutical composition (configuration, or dosage form) comprising segments linearly arranged in series like cars of a train. When the pharmaceutical composition is administrated into a patient's body, some of the segments are “visible” to an instrument, but others are not. However, “invisible” segments can be estimated, deduced, calculated, or inferred from “visible” segments. The “invisible” segments can be used for neutralizing intratumoral lactic acidosis combined with glucose deprivation to control tumor, among other applications.

traducir

BLOOD GLUCOSE MEASUREMENT DEVICE AND METHOD TO AUTOMATICALLY DETERMINE BLOOD GLUCOSE UNIT

NºPublicación: US2020008720A1 09/01/2020

Solicitante:

PHILOSYS CO LTD [KR]

EP_3593717_A1

Resumen de: US2020008720A1

Provided is a blood glucose measurement device and method. The blood glucose measurement device may determine a blood glucose unit to be provided to a user based on a user input and a region in which the device is positioned, and provide blood glucose data to the user using the determined blood glucose unit through a display.

traducir

CONTINUOUS GLUCOSE MONITORING ON-BODY SENSOR HAVING A VISUAL DISPLAY

NºPublicación: US2020008758A1 09/01/2020

Solicitante:

BECTON DICKINSON CO [US]

JP_2019025365_A

Resumen de: US2020008758A1

An on-body sensor (OBS) (10) having a continuous monitoring (CGM) device is disclosed for use in identifying an analyte, such as glucose in blood or interstitial fluid (ISF), using a biomaterial, such as glucose binding protein (GBP), that is brought into contact with the analyte. The on-body sensor (10) incorporating the CGM device includes a cover (25) which provides protection to the CGM device and includes an integrated output display (27). The output display (27) can visually provide data received from the CGM device, to the user without the need for a separate data receiving device.

traducir

DEVICE AND METHOD TO DETERMINE BLOOD GLUCOSE SENSING DATA

Nº publicación: US2020008750A1 09/01/2020

Solicitante:

PHILOSYS CO LTD [KR]

EP_3594956_A1

Resumen de: US2020008750A1

Provided is a device and method to determine blood glucose sensing data. The device may determine whether blood glucose sensing data is an error candidate based on a sampling value and a sampling slope of the blood glucose sensing data, and finally determine whether the blood glucose sensing data is error data by applying a blood glucose signal determination model to the error candidate.

traducir

Página1 de 5 nextPage por página

punteroimgVolver